Led end-to-end development and optimization of purification process of the adjuvant for HPV vaccine (Papilloguard), from initial R&D to cGMP manufacturing and technology transfer.
Was the key contributer to the design and implementation of downstream processing steps including chromatography, sterile filtration, and QC testing protocols.
Troubleshot purification challenges and suggested creative solutions to optimize process robustness and yields.
Provided hands-on training for production team on all downstream processing and analytical methods.
Established SOPs and qualification protocols ensuring alignment with USP guidelines and FDA regulations.
Managed technology transfer and scale-up to enable large-scale cGMP production of adjuvant.
Recognized for technical expertise in bioprocessing and ability to lead cross-functional teams.
Downstream Process Development Scientist
MOM Research And Innovation Center
12.2018 - 08.2019
Developed and optimized downstream purification process for lentiviral vectors used in CAR-T cancer immunotherapies for ALL and DLBCL.
Conducted comprehensive literature review of viral vector processing techniques. Gained hands-on experience with chromatography, filtration, and TFF operations.
Wrote vector production and purification sections for project proposals. Provided solutions for technical challenges through brainstorming sessions.
Research Intern
Virology Lab, University Of Tehran
01.2019 - 09.2019
Gained hands-on experience in viral vector production
Produced retroviral and lentiviral vectors using plasmid transfection of HEK293T cells.
Performed vector concentration and characterization via qPCR.
Assisted with cell culture, transfection, and analytical testing to support vector process development.
Developed technical skills in working under biosafety conditions and maintaining aseptic techniques.
Education
Graduate Certificate - Science And Technology Commercialization
Simon Fraser University
Vancouver, BC
08.2024
Master of Science - Biomedical And Molecular Sciences